Comments
Novartis' Certican succeeds in liver transplant trial
13.11.2012. | ZURICH (Reuters) - Swiss pharmaceutical company Novartis said on Monday its Certican, an immune system drug also known under the names Afinitor and Votubia, showed positive outcomes in a two-year phase III study in liver transplantation....
